Between 5% and 10% of patients with cardiovascular problems develop clots, estimates Donald Baim, an interventional cardiologist at Brigham and Women's Hospital in Boston, who is also a scientific adviser to OmniSonics, as well as a shareholder.
FORBES: OmniSonics' Clot Buster